Muhammet Özbilen: Is the IV Iron Given to Hospitalized Patients Sufficient?
Muhammet Özbilen, Associate Professor Doctor at Ordu University, shared a post on LinkedIn about a recent article by Joséphine A. Cool et al. published in AJH, adding:
“Is the IV iron given to hospitalized patients sufficient?
A paper published last month in the American Journal of Hematology paints a vivid picture.
The investigation was carried out at Harvard Medical School’s training hospital.
- More than 200,000 hospital admissions from 5 years were studied.
- Only 31.5% of anemic individuals had their iron levels checked.
- Only half (54%) of patients with iron deficiency anemia (IDA) were given iron supplements.
- The calculated median iron deficiency in patients receiving IV iron was 1,847 mg, while the median amount provided was only 500 mg.
So ‘Mind the Gap’ expresses just this: there is a 1,364 mg difference in the IV iron dose provided.
The cause for this big disparity can be described as follows:
- Iron measurements are commonly neglected when anemia is not the main reason for admission.
- The majority of DEA patients in this investigation were normocytic (median MCV: 86), contrary to expectations of microcytosis.
- Ferric gluconate is the most often used IV iron formulation with a low daily maximum dose. However, it is insufficient for non-dialysis patients and requires numerous doses.
- The present hospital treatment approach prioritizes acute stabilization over chronic disease management.
However, appropriate iron therapy has been shown to normalize hemoglobin levels within 8 weeks, reducing the need for outpatient IV iron.
Conclusion: DEA is underdiagnosed and undertreated in the inpatient context. To address this, physician education and system-level interventions are required.”
Title: Mind the Gap: Underdosing of Intravenous Iron in a Hospitalized Patient Population With Iron-Deficiency Anemia
Authors: Joséphine A. Cool, Linnea M. Wilson, Justine Blum, Jason A. Freed, Shoshana J. Herzig

Stay updated on all scientific advances with Hemostasis Today.
-
Jun 24, 2026, 09:29Advancing Women’s Health Through Collaboration with Jean Hailes for Women’s Health – Stroke Foundation
-
Jun 24, 2026, 09:18The Lasting Immunological Footprint of VITT – JTH
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care
-
Jun 24, 2026, 07:46Wolfgang Miesbach: WFH’s First AAV Gene Therapy Chapter Marks a New Era in Hemophilia Care
-
Jun 24, 2026, 06:42Deepthi Krishna: World Blood Donor Day 2026 Celebrations at Rela Hospital
-
Jun 24, 2026, 03:36Ana Pedrero Gil: A New Approach to Post-Tonsillectomy Hemorrhage
-
Jun 24, 2026, 02:59Melissa Hollo: Making Early Anemia Detection the Standard of Care
-
Jun 24, 2026, 02:51Bruno Pougault: The Thin Line Between Bleeding and Clotting